CSPI Newsroom
Return to the Center for Science in the Public Interest
For Immediate
Release:
February 6, 2003


Keep Updated:
Email updates
RSS syndication xml icon


Print Version

For more information, contact: phone 202.332.9110 fax 202.265.4954 Center for Science in the Public Interest, 1875 Connecticut Avenue, NW Washington, DC 20009

CSPI on Genetically Engineered Piglets

Statement of CSPI Biotechnology Director Gregory Jaffe

Although FDA has stated that the transgenic pigs from the University of Illinois/Urbana/ Champaign posed no risk to public health, this incident confirms that the current regulatory system is not adequately ensuring the safety of the food supply. Once again, the biotechnology industry and the government played russian roulette with the public and this time results are not harmful, but if these incidents keep occuring, the next time could be different.

This incident, as well as the recent Prodigene and StarLink incidents, confirm a practice by the biotechnology industry to ignore governmental restrictions and oversight. They also portray a governmental regulatory system desperately trying to play “catch up” with this fast-moving technology.

The current regulatory system for biotechnology is in dire need of overhaul. It is clear that antiquated statutes passed by Congress long before this technology existed, do not provide agencies such as FDA with the tools needed to oversee and regulate transgenic products.

The enormous promise of agricultural biotechnology will not be realized unless robust and sensible regulatory systems ensure the safety of products in an open and transparent manner. The message to consumers from this incident is that the current regulatory system is far from achieving that goal.